Zanders E D, Fischer A, Smith S, Beverley P C, Feldmann M
Immunology. 1983 Feb;48(2):361-6.
A T-cell line (H3) was established by culturing human peripheral blood mononuclear cells with influenza virus A/X31 and maintained in long term culture with Interleukin-2 (TCGF). Supernatants were prepared by culturing these cells overnight in the absence of Interleukin-2 but with A/X31 and irradiated autologous E rosette negative cells as a source of antigen presenting cells, and harvesting by centrifugation. The supernatants were shown to replace T cells in helping E- (B) cells to produce antibody specific to A/X31 which was measured by enzyme immunoassay (EIA). Although maximal help was obtained with autologous or semi allogeneic B cells (in the latter case bearing HLA-DR 3 loci) there was still significant antibody production with allogeneic combinations. The supernatants were subsequently fractionated into specific and non-specific helper activities by gel filtration, giving an approximate mol. wt of 50-70,000 and 10-30,000 for each respectively. The specific HF was shown to be genetically restricted in its action upon B cells and also to generate antibody to A/X31 only. The lower molecular weight material acted on any responding B cell regardless of HLA-DR type and produced antibody non-specifically in culture with E- cells even in the absence of antigen. The apparent lack of restriction was therefore due to the masking effect of non-specific and non-restricted HF(s) on the genetically restricted specific HF produced by this line.
通过用人外周血单核细胞与甲型流感病毒A/X31培养建立了一个T细胞系(H3),并用白细胞介素-2(TCGF)进行长期培养。在无白细胞介素-2但有A/X31和经照射的自体E花环阴性细胞(作为抗原呈递细胞来源)的情况下,将这些细胞培养过夜,然后通过离心收获上清液。通过酶免疫测定(EIA)检测发现,这些上清液在帮助E(B)细胞产生针对A/X31的特异性抗体方面可替代T细胞。尽管使用自体或半同种异体B细胞(在后一种情况下带有HLA - DR 3个位点)可获得最大的辅助作用,但同种异体组合仍有显著的抗体产生。随后通过凝胶过滤将上清液分离为特异性和非特异性辅助活性,其分子量分别约为50 - 70,000和1万 - 3万。特异性HF对B细胞的作用具有遗传限制性,并且仅产生针对A/X31的抗体。较低分子量的物质作用于任何反应性B细胞,而不考虑HLA - DR类型,并且即使在没有抗原的情况下,与E细胞共培养时也能非特异性地产生抗体。因此,明显缺乏限制性是由于非特异性和非限制性HF对该细胞系产生的具有遗传限制性的特异性HF的掩盖作用。